2Shi B, Liang J, Yang X, et al. Integration of estrogen and wnt signaling circuits by the polycomb group protein ezh2 in breast cancer Cells[J]. Mol Cell Biol, 2007, 27(14): 5105-5119.
3Schlange T, Matsuda Y, Lienhard S, et al, Autocrinc WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transaetivation[J]. Breast Cancer Res, 2007, 9(5): R63.
4Saitoh T, Katoh M. Expression profiles of betaTRCP/ and betaTRCP2, and mutation analysis of betaTRCP2 in gastric cancer [J]. Int J Oucol, 2001, 18(5) :959-964.
5Liu YT, Shang D, Akatsuka S, et al. Chronic oxidative stress causes amplification and of erexpression of ptprzl protein tyrosine phosphatase to activate beta-catenin pathway [ J]. Am J Pathol, 2007, 171(6) : 1978-1988.
6Umar S, Wang Y, Morris AP, et al. Dual alterations in casein kinase I-ε and GSK-3β modulate β-catenin stability in hyperproliferating colonic epithelia [ J ]. Am J Physiol Gastrointest Liver Physiol, 2007, 292:G599-G607.
7van Amerongen R, Berns A. Re-evaluating the role of Frat in Wntsignal transduction[J]. Cell Cycle, 2005, 4(8) : 1065-1072.
8Kadoya T, Kishida S, Fukui A, et al. Inhibition of Wnt signaling pathway by a novel Axin-binding proteln[J]. J Biol Chem, 2000, 275(47) : 37030-37037.
9Amit S, Hatzubai A, Birman Y, et al. Axin-mediated CKI phosphorylation of β-catenin at Set 45 : a molecular switch for the Wnt pathway[J]. Genes Dev, 2002, 16(9): 1066-1076.
10Ferkey DM, Kimelman D. Glycogen synthase kinase-3 beta mutagenesis identifies a common binding domain for GBP and Axin [J]. J Biol Chem, 2002, 277(18): 16147-16152.
1Johnson RL, Rothman AL, Xie J, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome[J] . Science, 1996, 272 (5268) : 1668-1671.
2Mikami M, Nosho K, Yamamoto H, et al. Mutational analysis ofbeta-catenin and the RAS--RAF signalling pathway in early fiat- -type colorectal tumours[J]. Eur J Cancer, 2006, 42 (17) : 3065-3072.
4Zhou X, TanM, Stone Hawthome V, et al. Activation of the Akt/mammalian target of Rapamycin/4E-BP 1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers[J].Clin Cancer Res, 2004, 10: 6779-6788.
